Dear DME MAC Medical Directors:
"The Endocrine Society is pleased to offer the following comments on the proposed local coverage determination (LCD) for Continuous Glucose Monitors (CGM). Founded in 1916, the Society represents approximately 18,000 physicians and scientists engaged in the treatment and research of all endocrine disorders, including diabetes. Our membership is also made up of over 11,000 clinicians who are the leaders in the treatment of diabetes. We have authored clinical practice guidelines in diabetes technology, diabetes and pregnancy, and treatment of diabetes in older adults. As such, our members are knowledgeable about the challenges patients with diabetes face controlling their condition and have found that various types of diabetes technology have significantly improved the quality of their patients’ lives."
